Electrical Stimulation Therapy: A Promising Approach to Vision Loss in Glaucoma and Other Optic Neuropathies

CVI a leading cause of visual impairment in children but often overlooked

Phase 2 DAVIO 2 Clinical Trial Results

Impact of Prior DME Treatment on Aflibercept 8 mg Outcomes

Video: Diabetic Macular Edema Study Results

WILLS EYE GLAUCOMA LEADER RECEIVES $6.2 MILLION NIH AWARD FOR VISION RESEARCH

New Gene Therapy for Retinitis Pigmentosa Shows Promise

Wills to Present Study Results that Aid Detection of ATTR

STUDY RESULTS ON ENDOPHTHALMITIS RATES AND TYPES OF TREATMENTS AFTER INTRAOCULAR PROCEDURES

Wills Study: Post-op Endophthalmitis Rates Down Fourfold Over 20-Year Period

Wills Residents Offer Strategies for AI in Healthcare

New Treatment for Dry Macular Degeneration

Glaucoma Visionary Joel S. Schuman, MD to Join Wills Eye Hospital

Dr. Carol Shields Notes Possible Paradigm Shift in Treatment for Uveal Melanoma

Emerging Treatments for Wet AMD

WILLS EYE HOSPITAL AND PENN MEDICINE RETINA RESEARCH FIND IMPROVEMENT FOR NIGHT VISION IN ADULTS WITH CONGENITAL BLINDNESS